PFIZER INC. for PFIZER INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Intellectual Property Protections and Policy S. 2658 - Medication Affordability and Patent Integrity Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| ANGELA BOOTHE WILES | — |
Health Issues HCR
Vaccine Coverage and Coverage Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Codification and Sec. 301 trade investigations FDA User Fee Agreements: 2027 PDUFA Cycle H.R. 7837 - Most Favored Patient Act of 2026 H.R. 7391 - Community Health Center Drug Pricing Protection Act 340B Program Reform Inflation Reduction Act (IRA) H.R. 8646 - Agriculture, Rural Development, Food and Drug Administration, and Related Agency Appropriates Act, 2027 H.R. 9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriation Act, 2027 H.R. 5178 - Sickle Cell Disease Comprehensive Care Act H.R. 5526 - Biosimilars Red Tape Elimination Act H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade H.R. 4299 - Protecting Patient Access to Cancer and Complex Therapies Act: IRA reforms Prior Authorization Step Therapy Practices FDA Modernization and Reforms Drug Pricing PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANCISCO CARRILLO | — |
| EMILY MUELLER | — |
| MATTHEW STROIA | — |
| JENNIFER SWENSON WALTON | — |
| ANGELA BOOTHE WILES | — |
Medicare/Medicaid MMM
H.R. 7391 - Community Health Center Drug Pricing Protection Act Executive Order 14297 - Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients Vaccine Access and Coverage 340B Program Reform PBM Reform Direct-to-Patient Prescription Drug Purchase Platforms and Insurance Coverage Step Therapy Practices Drug Pricing Medicare/Medicaid Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| FRANCISCO CARRILLO | — |
| EMILY MUELLER | — |
| MATTHEW STROIA | — |
| JENNIFER SWENSON WALTON | — |
| ANGELA BOOTHE WILES | — |
Taxation/Internal Revenue Code TAX
H.R. 1 - An Act to Provide for Reconciliation Pursuant to Title II of H. Con. Res. 14
| Lobbyist | Covered position, as disclosed |
|---|---|
| MATTHEW STROIA | — |
Trade (domestic/foreign) TRD
H.R. 9102 - Biotech Investment National Security Act (BINSA) Act: US Competitiveness, Biotechnology H.R. 4930 - To Expand the Sharing of Information with Respect to Suspected Violations of Intellectual Property Rights in Trade International Supply Chain Section 301 Investigation re: Germany Issues Market Access Most Favored Nation Policies Foreign Freeriding Issues Non-Tariff Trade Barriers Competitiveness Issues Trade Issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| STEPHEN CLAEYS | — |
| EMILY MUELLER | — |
| CATHERINE ROBINSON | — |
| MATTHEW STROIA | — |
| JENNIFER SWENSON WALTON | — |
| ANGELA BOOTHE WILES | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.